Education
About Us
Working with TipRanks
Follow Us
Bluejay Diagnostics (BJDX)
NASDAQ:BJDX
RESEARCH TOOLSreports
Total Valuation
Bluejay Diagnostics has a market cap or net worth of $2.69M. The enterprise value is $3.38B.
Market Cap$2.69M
Enterprise Value$3.38B
Share Statistics
Bluejay Diagnostics has 1,494,182 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,494,182
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bluejay Diagnostics’s return on equity (ROE) is -1.35 and return on invested capital (ROIC) is -120.29%.
Return on Equity (ROE)-1.35
Return on Assets (ROA)-1.16
Return on Invested Capital (ROIC)-120.29%
Return on Capital Employed (ROCE)-1.23
Revenue Per Employee0.00
Profits Per Employee-1.10M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bluejay Diagnostics is -0.12. Bluejay Diagnostics’s PEG ratio is -0.28.
PE Ratio-0.12
PS Ratio0.00
PB Ratio33.19
Price to Fair Value0.16
Price to FCF-42.84
Price to Operating Cash Flow-49.47
PEG Ratio-0.28
Income Statement
In the last 12 months, Bluejay Diagnostics had revenue of 0.00 and earned -7.72M in profits. Earnings per share was -42.08.
Revenue0.00
Gross Profit0.00
Operating Income-7.17M
Pretax Income-7.72M
Net Income-7.72M
EBITDA-6.70M
Earnings Per Share (EPS)-42.08
Cash Flow
In the last 12 months, operating cash flow was -6.44M and capital expenditures -271.35K, giving a free cash flow of -6.71M billion.
Operating Cash Flow-6.44M
Free Cash Flow-6.71M
Free Cash Flow per Share-4.49
Dividends & Yields
Bluejay Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-99.13%
50-Day Moving Average2.11
200-Day Moving Average4.18
Relative Strength Index (RSI)46.93
Average Volume (3m)1.55M
Important Dates
Bluejay Diagnostics upcoming earnings date is Apr 16, 2025, TBA Not Confirmed.
Last Earnings DateNov 7, 2024
Next Earnings DateApr 16, 2025
Ex-Dividend Date―
Financial Position
Bluejay Diagnostics as a current ratio of 6.05, with Debt / Equity ratio of 4.27%
Current Ratio6.05
Quick Ratio6.05
Debt to Market Cap0.13
Net Debt to EBITDA0.61
Interest Coverage Ratio-8.71
Taxes
In the past 12 months, Bluejay Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bluejay Diagnostics EV to EBITDA ratio is 0.48, with an EV/FCF ratio of 0.39.
EV to Sales0.00
EV to EBITDA0.48
EV to Free Cash Flow0.39
EV to Operating Cash Flow0.41
Balance Sheet
Bluejay Diagnostics has $3.12M in cash and marketable securities with $187.37K in debt, giving a net cash position of -$2.93M billion.
Cash & Marketable Securities$3.12M
Total Debt$187.37K
Net Cash-$2.93M
Net Cash Per Share-$1.96
Tangible Book Value Per Share$31.24
Margins
Gross margin is 19.64%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin19.64%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bluejay Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast81.35%